Review: Bupropion and SSRI-induced side effects

Journal of Psychopharmacology

Volumn 22, Issue 7, 2008, Pages 792-804

  Demyttenaere, K ^a   Jaspers, L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Bupropion; Emotional detachment; Serotonin reuptake inhibitors; Sexual dysfunction; Weight gain

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; OLANZAPINE; PAROXETINE; PLACEBO; PSYCHOTROPIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ADD ON THERAPY; ANORGASMIA; ARTICLE; CLINICAL TRIAL; DEPRESSION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; EJACULATION DISORDER; EMOTIONAL DISORDER; ERECTILE DYSFUNCTION; FATIGUE; HUMAN; IMPOTENCE; INSOMNIA; LIBIDO; LIBIDO DISORDER; LONG TERM CARE; LOW DRUG DOSE; MEDLINE; MONOTHERAPY; MOTIVATION; OBSESSIVE COMPULSIVE DISORDER; ORGASM DISORDER; PREVALENCE; PRIORITY JOURNAL; SEXUAL AROUSAL; SEXUAL AROUSAL DISORDER; SEXUAL DYSFUNCTION; SIDE EFFECT; SOMNOLENCE; VAGINA DISEASE; VAGINAL LUBRICATION; WEIGHT GAIN; WEIGHT REDUCTION;

AFFECTIVE SYMPTOMS; BUPROPION; DEPRESSION; DOPAMINE UPTAKE INHIBITORS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEROTONIN UPTAKE INHIBITORS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; WEIGHT GAIN;

EID: 50249149814     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107083798     Document Type: Article

References (91)

1. Anderson J.W., Greenway F.L., Fujioka K., Gadde K.M., McKenney J., O'Neil P.M. (2002) Bupropion S R enhances weight loss: a 48-week double-blind, placebo- controlled trial. Obes Res 10: 633-641
2. Ashton A.K., Rosen R.C. (1998) Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 59: 2-5
3. Baldwin D.S. (2001) Depression and sexual dysfunction. Br Med Bull 57: 81-99
4. Baldwin D.S., Papakostas G.I. (2006) Symptoms of fatigue and sleepiness in major depressive disorder. J Clin Psychiatry 67 (Suppl 6). 9-15
5. Balon R. (2002) Emotional blunting, sexual dysfunction and SSRIs. Int J Neuropsychopharmacol 5: 415-416 ; author reply 417
6. Balon R. (2006) SSRI-associated sexual dysfunction. Am J Psychiatry 163: 1504-1509 ; quiz 1664
7. Bauer M., Whybrow P.C., Angst J., Versiani M., Moller H.J. (2002 a) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and continuation treatment of major depressive disorder. World J Biol Psychiatry 3: 5-43
8. Bauer M., Whybrow P.C., Angst J., Versiani M., Moller H.J. (2002 b) World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World J Biol Psychiatry 3: 69-86
9. Bolling M.Y., Kohlenberg R.J. (2004) Reasons for quitting serotonin reuptake inhibitor therapy: paradoxical psychological side effects and patient satisfaction. Psychother Psychosom 73: 380-385
10. Clayton A.H., McGarvey E.L., Abouesh A.I., Pinkerton R.C. (2001) Substitution of an SSRI with bupropion sustained release following SSRI-induced sexual dysfunction. J Clin Psychiatry 62: 185-190
11. Clayton A.H., Pradko J.F., Croft H.A., Montano C.B., Leadbetter R.A., Bolden-Watson C., Bass K.I., Donahue R.M., Jamerson B.D., Metz A. (2002) Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 63: 357-366
12. Clayton A.H., Warnock J.K., Kornstein S.G., Pinkerton R., Sheldon-Keller A., McGarvey E.L. (2004) A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 65: 62-67
13. Clayton A., Keller A., McGarvey E.L. (2006 a) Burden of phase-specific sexual dysfunction with SSRIs. J Affect Disord 91: 27-32
14. Clayton A.H., Croft H.A., Horrigan J.P., Wightman D.S., Krishen A., Richard N.E., Modell J.G. (2006 b) Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 67: 736-746
15. Coleman C.C., Cunningham L.A., Foster V.J., Batey S.R., Donahue R.M., Houser T.L., Ascher J.A. (1999) Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry 11: 205-215
16. Coleman C.C., King B.R., Bolden-Watson C., Book M.J., Segraves R.T., Richard N., Ascher J., Batey S., Jamerson B., Metz A. (2001) A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin Ther 23: 1040-1058
17. Corcoran C., Wong M. L, O' Keane V. (2004) Bupropion in the management of apathy. J Psychopharmacol 18: 133-135
18. Crenshaw T.L., Goldberg J.P., Stern W.C. (1987) Pharmacologic modification of psychosexual dysfunction. J Sex Marital Ther 13: 239-252
19. Croft H., Settle E., Jr., Houser T., Batey S.R., Donahue R.M., Ascher J.A. (1999) A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin Ther 21: 643-658
20. Croft H., Houser T. L, Jamerson B.D., Leadbetter R., Bolden-Watson C., Donahue R., Metz A. (2002) Effect on body weight of bupropion sustained-release in patients with major depression treated for 52 weeks. Clin Ther 24: 662-672
21. DeBattista C., Solvason B., Poirier J., Kendrick E., Loraas E. (2005) A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction. J Clin Psychiatry 66: 844-848
22. Demyttenaere K., Enzlin P., Dewe W., Boulanger B., De Bie J., De Troyer W., Mesters P. (2001) Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. J Clin Psychiatry 62 (Suppl 22). 30-33
23. Dobkin R.D., Menza M., Marin H., Allen L.A., Rousso R., Leiblum S.R. (2006) Bupropion improves sexual functioning in depressed minority women: an open-label switch study. J Clin Psychopharmacol 26: 21-26
24. Dording C.M., Mischoulon D., Petersen T.J., Kornbluh R., Gordon J., Nierenberg A.A., Rosenbaum J.E., Fava M. (2002) The pharmacologic management of SSRI-induced side effects: a survey of psychiatrists. Ann Clin Psychiatry 14: 143-147
25. Ekselius L., von Knorring L. (2001) Effect on sexual function of long-term treatment with selective serotonin reuptake inhibitors in depressed patients treated in primary care. J Clin Psychopharmacol 21: 154-160
26. Fava M. (2000) Weight gain and antidepressants. J Clin Psychiatry 61 (Suppl 11). 37-41
27. Fava M. (2003) Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment. J Clin Psychiatry 64 (Suppl 14). 30-34
28. Fava M., Rankin M. (2002) Sexual functioning and SSRIs. J Clin Psychiatry 63 (Suppl 5). 13-16 ; discussion 23-25
29. Fava M., Amsterdam J.D., Deltito J.A., Salzman C., Schwaller M., Dunner D.L. (1998) A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Ann Clin Psychiatry 10: 145-150
30. Fava M., Rush A.J., Thase M.E., Clayton A., Stahl S.M., Pradko J.F., Johnston J.A. (2005) 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry 7: 106-113
31. Fava M., Graves L.M., Benazzi F., Scalia M.J., Iosifescu D.V., Alpert J.E., Papakostas G.I. (2006) A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. J Clin Psychiatry 67: 1754-1759
32. Feiger A., Kiev A., Shrivastava R.K., Wisselink P.G., Wilcox C.S. (1996) Nefazodone versus sertraline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction. J Clin Psychiatry 57 (Suppl 2). 53-62
33. Feighner J.P., Gardner E.A., Johnston J.A., Batey S.R., Khayrallah M.A., Ascher J.A., Lineberry C.G. (1991) Double-blind comparison of bupropion and fluoxetine in depressed outpatients. J Clin Psychiatry 52: 329-335
34. Gadde K.M., Parker C.B., Maner L.G., Wagner H.R. 2nd, Logue E.J., Drezner M.K., Krishnan K.R. (2001) Bupropion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res 9: 544-551
35. Gadde K.M., Zhang W., Foust M.S. (2006) Bupropion treatment of olanzapine-associated weight gain: an open-label, prospective trial. J Clin Psychopharmacol 26: 409-413
36. Garland E.J., Baerg E.A. (2001) Amotivational syndrome associated with selective serotonin reuptake inhibitors in children and adolescents. J Child Adolesc Psychopharmacol 11: 181-186
37. Gitlin M.J., Suri R., Altshuler L., Zuckerbrow-Miller J., Fairbanks L. (2002) Bupropion-sustained release as a treatment for SSRI-induced sexual side effects. J Sex Marital Ther 28: 131-138
38. Green T.R. (1997) Bupropion for SSRI-induced fatigue. J Clin Psychiatry 58: 174
39. Gregorian R.S., Golden K.A., Bahce A., Goodman C., Kwong W.J., Khan Z.M. (2002) Antidepressant-induced sexual dysfunction. Ann Pharmacother 36: 1577-1589
40. Harto-Truax N., Stern W.C., Miller L.L., Sato T.L., Cato A.E. (1983) Effects of bupropion on body weight. J Clin Psychiatry 44: 183-186
41. Healy D. (2000) Reboxetine: its effects as measured by the Social Adaptation Self-evaluation Scale. Acta Psychiatr Scand Suppl 402: 45-51
42. Hoehn-Saric R., Lipsey J.R., McLeod D.R. (1990) Apathy and indifference in patients on fluvoxamine and fluoxetine. J Clin Psychopharmacol 10: 343-345
43. Hu X.H., Bull S.A., Hunkeler E.M. et al. (2004) Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. J Clin Psychiatry 65: 959-965
44. Jain A.K., Kaplan R.A., Gadde K.M., Wadden T.A., Allison D.B., Brewer E.R., Leadbetter R.A., Richard N., Haight B., Jamerson B.D., Buaron K.S., Metz A. (2002) Bupropion SR vs. placebo for weight loss in obese patients with depressive symptoms. Obes Res 10: 1049-1056
45. Jamerson B.D., Krishnan K.R., Roberts J., Krishen A., Modell J.G. (2003) Effect of bupropion SR on specific symptom clusters of depression: analysis of the 31-item Hamilton Rating Scale for depression. Psychopharmacol Bull 37: 67-78
46. Jefferson J.W., Rush A.J., Nelson J.C., VanMeter S.A., Krishen A., Hampton K.D., Wightman D.S., Modell J.G. (2006) Extended-release Bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: Findings from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 67: 865-873
47. Kavoussi R.J., Segraves R.T., Hughes A.R., Ascher J.A., Johnston J.A. (1997) Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. J Clin Psychiatry 58: 532-537
48. Kennedy S.H., Eisfeld B.S., Dickens S.E., Bacchiochi J.R., Bagby R.M. (2000) Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry 61: 276-281
49. Kennedy S.H., Fulton K.A., Bagby R.M., Greene A.L., Cohen N.L., Rafi-Tari S. (2006) Sexual function during bupropion or paroxetine treatment of major depressive disorder. Can J Psychiatry 51: 234-242
50. Kennedy S.H., McCann S.M., Masellis M., McIntyre R.S., Raskin J., McKay G., Baker G.B. (2002) Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. J Clin Psychiatry 63: 181-186
51. Kiev A., Feiger A. (1997) A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients. J Clin Psychiatry 58: 146-152
52. Labbate L.A., Grimes J. B, Hines A., Pollack M.H. (1997) Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry 9: 241-245
53. Labbate L.A., Brodrick P.S., Nelson R.P., Lydiard R.B., Arana G.W. (2001) Effects of bupropion sustained-release on sexual functioning and nocturnal erections in healthy men. J Clin Psychopharmacol 21: 99-103
54. Landen M., Hogberg P., Thase M.E. (2005) Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine. J Clin Psychiatry 66: 100-106
55. Lee S.I., Keltner N.L. (2005) Antidepressant apathy syndrome. Perspect Psychiatr Care 41: 188-192
56. Maddox J C L M, Thompson C. (1994) The compliance with antidepressants in general practice. J Psychopharmacol 8: 48-53
57. Maina G., Albert U., Salvi V., Bogetto F. (2004) Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors. J Clin Psychiatry 65: 1365-1371
58. Marangell L.B., Johnson C.R., Kertz B., Zboyan H.A., Martinez J.M. (2002) Olanzapine in the treatment of apathy in previously depressed participants maintained with selective serotonin reuptake inhibitors: an open-label, flexible-dose study. J Clin Psychiatry 63: 391-395
59. Marin R.S., Fogel B.S., Hawkins J., Duffy J., Krupp B. (1995) Apathy: a treatable syndrome. J Neuropsychiatry Clin Neurosci 7: 23-30
60. Masand P.S., Gupta S. (2002) Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine. Ann Clin Psychiatry 14: 175-182
61. Masand P.S., Ashton A.K., Gupta S., Frank B. (2001) Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am J Psychiatry 158: 805-807
62. Menza M., Marin H., Opper R.S. (2003) Residual symptoms in depression: can treatment be symptom-specific? J Clin Psychiatry 64: 516-523
63. Michelson D., Amsterdam J.D., Quitkin F.M., Reimherr F.W., Rosenbaum J.F., Zajecka J., Sundell K.L., Kim Y., Beasley C.M. Jr. (1999) Changes in weight during a 1-year trial of fluoxetine. Am J Psychiatry 156: 1170-1176
64. Modell J.G., Katholi C.R., Modell J.D., DePalma R.L. (1997) Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. Clin Pharmacol Ther 61: 476-487
65. Modell J.G., May R.S., Katholi C.R. (2000) Effect of bupropion-SR on orgasmic dysfunction in nondepressed subjects: a pilot study. J Sex Marital Ther 26: 231-240
66. Montejo A.L., Llorca G., Izquierdo J.A., Rico-Villademoros F. (2001) Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 62 (Suppl 3). 10-21
67. Montejo-González A.L., Llorca G., Izquierdo J.A., Ledesma A., Bousoño M., Calcedo A., Carrasco J.L., Ciudad J., Daniel E., De la Gandara J., Derecho J., Franco M., Gomez M.J., Macias J.A., Martin T., Perez V., Sanchez J.M., Sanchez S., Vicens E. (1997) SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J Sex Marital Ther 23: 176-194
68. Montgomery S.A., Baldwin D.S., Riley A. (2002) Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J Affect Disord 69: 119-140
69. Myers E.D., Branthwaite A. (1992) Out-patient compliance with antidepressant medication. Br J Psychiatry 160: 83-86
70. Oleshansky M.A., Labbate L.A. (1996) Inability to cry during SRI treatment. J Clin Psychiatry 57: 593
71. Olfson M., Marcus S.C., Tedeschi M., Wan G.J. (2006) Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 163: 101-108
72. Opbroek A., Delgado P.L., Laukes C., McGahuey C., Katsanis J., Moreno F.A., Manber R. (2002) Emotional blunting associated with SSRI-induced sexual dysfunction. Do SSRIs inhibit emotional responses? Int J Neuropsychopharmacol 5: 147-151
73. Papakostas G.I., Nutt D. J, Hallett L.A., Tucker V.L., Krishen A., Fava M. (2006) Resolution of sleepiness and fatigue in major depressive disorder: a comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry 60: 1350-1355
74. Reimherr F.W., Chouinard G., Cohn C.K., Cole J.O., Itil T.M., LaPierre Y.D., Masco H.L., Mendels J. (1990) Antidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 51 (Suppl B). 18-27
75. Reimherr F.W., Cunningham L.A., Batey S.R., Johnston J.A., Ascher J.A. (1998) A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients. Clin Ther 20: 505-516
76. Reinblatt S.P., Riddle M.A. (2006) Selective serotonin reuptake inhibitor-induced apathy: a pediatric case series. J Child Adolesc Psychopharmacol 16: 227-233
77. Rosen R.C., Lane R.M., Menza M. (1999) Effects of SSRIs on sexual function: a critical review. J Clin Psychopharmacol 19: 67-85
78. Rosenberg K.P., Bleiberg K.L., Koscis J., Gross C. (2003) A survey of sexual side effects among severely mentally ill patients taking psychotropic medications: impact on compliance. J Sex Marital Ther 29: 289-296
79. Rowland D.L., Myers L., Culver A., Davidson J.M. (1997) Bupropion and sexual function: a placebo-controlled prospective study on diabetic men with erectile dysfunction. J Clin Psychopharmacol 17: 350-357
80. Segraves R.T. (1998) Antidepressant-induced sexual dysfunction. J Clin Psychiatry 59 (Suppl 4). 48-54
81. Segraves R.T., Kavoussi R., Hughes A.R., Batey S.R., Johnston J.A., Donahue R., Ascher J.A. (2000) Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment. J Clin Psychopharmacol 20: 122-128
82. Segraves R.T., Clayton A., Croft H., Wolf A., Warnock J. (2004) Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 24: 339-342
83. Settle E.C., Stahl S.M., Batey S.R., Johnston J.A., Ascher J.A. (1999) Safety profile of sustained-release bupropion in depression: results of three clinical trials. Clin Ther 21: 454-463
84. Simon G.E., VonKorff M., Wagner E.H., Barlow W. (1993) Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 15: 399-408
85. Stahl S.M., Zhang L., Damatarca C., Grady M. (2003) Brain circuits determine destiny in depression: a novel approach to the psychopharmacology of wakefulness, fatigue, and executive dysfunction in major depressive disorder. J Clin Psychiatry 64 (Suppl 14). 6-17
86. Stahl S.M., Pradko J.F., Haight B.R., Modell J.G., Rockett C.B., Learned-Coughlin S. (2004) A Review of the Neuropharmacology of Bupropion, a Dual Norepinephrine and Dopamine Reuptake Inhibitor. Prim Care Companion J Clin Psychiatry 6: 159-166
87. Walker P.W., Cole J.O., Gardner E.A., Hughes A.R., Johnston J.A., Batey S.R., Lineberry C.G. (1993) Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J Clin Psychiatry 54: 459-465
88. Weihs K.L., Settle E.C., Jr., Batey S.R., Houser T.L., Donahue R.M., Ascher J.A. (2000) Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. J Clin Psychiatry 61: 196-202
89. Weihs K.L., Houser T.L., Batey S.R., Ascher J.A., Bolden-Watson C., Donahue R.M., Metz A. (2002) Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression. Biol Psychiatry 51: 753-761
90. Williams V.S., Baldwin D.S., Hogue S.L., Fehnel S.E., Hollis K.A., Edin H.M. (2006) Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry 67: 204-210
91. Zimmerman M., Posternak M.A., Attiullah N., Friedman M., Boland R.J., Baymiller S., Berlowitz S.L., Rahman S., Uy K.K., Singer S., Chelminski I. (2005) Why isn't bupropion the most frequently prescribed antidepressant? J Clin Psychiatry 66: 603-610